Skip to main content

Table 6 Distribution of genotypes in patients with AT and in patients without thyroid impairment

From: Association between genetic mutations and the development of autoimmune thyroiditis in patients with chronic hepatitis C treated with interferon alpha

SNP

Genotypes

AT (n=18)

No thyroid impairment (n=62)

C1858T

CC

12 (66.7%)

49 (79.0%)

 

CT

6 (33.3%)

12 (19.4%)

 

TT

0 (0.0%)

1 (1.6%)

 

p=0.41034

A49G

AA

7 (38.9%)

26 (41.9%)

 

AG

11 (61.1%)

36 (58.1%)

 

GG

0 (0.0%)

0 (0.0%)

 

p=0.81720

C(−318)T

CC

14 (77.8%)

47 (75.8%)

 

CT

4 (22.2%)

13 (21.0%)

 

TT

0 (0.0%)

2 (3.2%)

 

p=0.74153